Plus Therapeutics's market cap is currently $81.51M. The company's EPS TTM is $0.02; its P/E ratio is ―; Plus Therapeutics is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
